Pharmaceutical Market Europe • April 2023 • 3

COMMENT

New beginnings

Spring is always a time for new beginnings, with people – not just trees! – turning over a new leaf. The warmer weather encourages us to venture out to get more exercise, after spending time indoors during the winter months, and the benefits of behaviour change come to the fore.

Behaviour change is one of healthcare’s greatest challenges and language is important when we talk about this particular topic.
In Danny Buckland’s article this month, he looks at why behaviour change ‘is a loaded phrase, freighted with aspiration and hope yet burdened with misunderstanding and mistrust’.

As Danny says: ‘The looming global health issues are huge, but healthcare is at an ideal moment for change thanks to accelerating digital capabilities, rapidly advancing medical science, easier identification and associations with patient groups, along with a halo effect from industry’s pandemic performance.’

He adds: ‘How these positives are deployed will be hugely influential in realising a beneficial impact on individuals and healthcare systems.’ Read more on page 24.

In our article by Gen Li, President and Founder of Phesi, he talks about the power of data to future-proof the clinical development industry and using the data gathered over the past five years to become more resilient to future challenges. Read more on page 16.

Looking ahead, our May issue will focus on the importance of creating effective patient pathways. Adopting the latest health innovations is vital in creating effective patient pathways, but along with that, it is equally important to include the patient voice.

If you would like to make your voice heard on this topic, please get in touch at sales@pmlive.com

I hope you enjoy this issue!

Image

Iona Everson
Group Managing Editor

Keep up to date with the latest developments in the UK and global healthcare marketplace – sign up to daily or weekly news alerts and fortnightly or monthly bulletins on specific topics at  www.pmlive.com/register

Image

THE TEAM
Editorial:
Group Managing Editor
Iona Everson

Journalist/editorial assistant
Emily Kimber


Studio:
Executive Director
Karl Equi

Sales:
Business Director
Tara Lovegrove

EDITORIAL ADVISORY BOARD
Philip Atkinson
Founder of Hive-Logic, Lifescience Transformation
Uday Bose
Corporate vice president, head of global marketing oncology, Boehringer Ingelheim
Dr Luc Hermans
VP commercial planning and operations Europe, Asia, Middle East, Gilead Sciences
Stefan Janssens
President EMEA, Cegedim Dendrite
John Morris
Partner, KPMG
Paul Pay
Chief business development officer, Norgine
Mark Rothera
Chief executive officer, Orchard Therapeutics
Ian Talmage
Senior vice president, global marketing, general medicine, Bayer Pharmaceuticals

PUBLISHED BY
PMGroup
Mansard House, Church Road, Little Bookham, Surrey, KT23 3JG, UK
Tel: +44 (0)1372 414200
Fax: +44 (0)1372 414201

CONTACT US
General enquiries: info@pmlive.com
Editorial: editor@pmlive.com
Advertising: sales@pmlive.com
Subscriptions: subscriptions@pmlive.com

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.
© 2023 PMGroup
All rights reserved. No part of this publication may be copied, reproduced, transmitted, photocopied, recorded or stored on any retrieval system without the prior written consent of the publishers.
The magazine is also available at the following subscription rates: £120 UK, £180 Europe, £210 RoW

Image